320 Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs
โ Scribed by Liaw, Yun-Fan; Chang, Ting-Tsung; Wu, Shun-Sheng; Schiff, Eugene R.; Han, Kwang-Hyub; Lai, Ching-Lung; Safadi, Rifaat; Lee, Samuel S.; Halota, Waldemar; Goodman, Zachary D.; Zhang, Hui; Iloeje, Uchenna H.; Beebe, Suzanne; Kreter, Bruce; Ishikawa, Hiroki; Katano, Yoshiaki; Takaguchi, Koichi; Omata, Masao
- Book ID
- 123457262
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 131 KB
- Volume
- 136
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
One year of treatment with entecavir (0.5 mg daily) in nucleoside-naive patients with hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis B (CHB) resulted in significantly improved liver histology and virological and biochemical endpoints in comparison with lamivudine. Patient